Castle Biosciences, Inc. provided revenue guidance for the full year 2022. The company anticipated generating between $115-120 million in total revenue in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.15 USD | +0.52% | -0.47% | +7.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.28% | 639M | |
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
+15.67% | 2B |
- Stock Market
- Equities
- CSTL Stock
- News Castle Biosciences, Inc.
- Castle Biosciences, Inc. Provides Revenue Guidance for the Full Year 2022